Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 3.208
Filter
1.
J Sports Sci Med ; 23(2): 317-325, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38841630

ABSTRACT

People with overweight or obesity preferred high-intensity interval training (HIIT) due to the time-efficiency and pleasure. However, HIIT leads to delayed onset muscle soreness (DOMS). The present study aimed to investigate the effects of omega-3 supplementation on DOMS, muscle damage, and acute inflammatory markers induced by cycling HIIT in untrained males with overweight or obesity. A randomized, double-blinded study was used in the present study. Twenty-four males with a sedentary lifestyle were randomly assigned to either receive omega-3 (O3) (4 g fish oil) or placebo (Con). Subjects consumed the capsules for 4 weeks and performed cycling HIIT at the 4th week. After 4 weeks-intervention, the omega-3 index of O3 group increased by 52.51% compared to the baseline. All subjects performed HIIT at 4th week. The plasma creatine kinase (CK) level of Con group increased throughout 48h after HIIT. While the CK level of O3 group increased only immediately and 24h after HIIT and decreased at 48h after HIIT. The white blood cell count (WBC) of Con group increased immediately after the HIIT, while O3 group did not show such increase. There was no change of CRP in both groups. O3 group had a higher reduction of calf pain score compared to Con group. O3 group also showed a recovery of leg strength faster than Con group. Omega-3 supplementation for 4 weeks lower increased CK level, reduced calf pain score, and recovery leg strength, DOMS markers after cycling HIIT.


Subject(s)
Bicycling , C-Reactive Protein , Creatine Kinase , Dietary Supplements , Fatty Acids, Omega-3 , High-Intensity Interval Training , Myalgia , Obesity , Overweight , Humans , Male , Myalgia/prevention & control , Myalgia/etiology , Myalgia/therapy , Double-Blind Method , Creatine Kinase/blood , Fatty Acids, Omega-3/administration & dosage , Overweight/therapy , Obesity/therapy , Young Adult , C-Reactive Protein/analysis , C-Reactive Protein/metabolism , Bicycling/physiology , Adult , Leukocyte Count , Muscle, Skeletal/drug effects , Biomarkers/blood , Sedentary Behavior
2.
J Sports Sci Med ; 23(2): 326-341, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38841639

ABSTRACT

In the recent past, practical blood flow restriction (pBFR) using non-pneumatic, usually elastic cuffs has been established as a cost-effective alternative to traditional blood flow restriction (BFR) using pneumatic cuffs, especially for training in large groups. This study investigated whether low-load resistance exercise with perceptually primed pBFR using an elastic knee wrap is suitable to induce similar motor performance fatigue as well as physiological and perceptual responses compared to traditional BFR using a pneumatic nylon cuff in males and females. In a randomized, counterbalanced cross-over study, 30 healthy subjects performed 4 sets (30-15-15-15 repetitions) of unilateral knee extensions at 20% of their one-repetition-maximum. In the pBFR condition, each individual was perceptually primed to a BFR pressure corresponding to 60% of their arterial occlusion pressure. Before and after exercise, maximal voluntary torque, maximal muscle activity, and cuff pressure-induced discomfort were assessed. Moreover, physiological (i.e., muscle activity, muscle oxygenation) and perceptual responses (i.e., effort and exercise-induced leg muscle pain) were recorded during exercise. Moderate correlations with no differences between pBFR and BFR were found regarding the decline in maximal voluntary torque and maximal muscle activity. Furthermore, no to very strong correlations between conditions, with no differences, were observed for muscle activity, muscle oxygenation, and perceptual responses during exercise sets. However, cuff pressure-induced discomfort was lower in the pBFR compared to the BFR condition. These results indicate that low-load resistance exercise combined with perceptually primed pBFR is a convenient and less discomfort inducing alternative to traditional BFR. This is especially relevant for BFR training with people who have a low cuff-induced discomfort tolerance.


Subject(s)
Cross-Over Studies , Muscle Fatigue , Muscle, Skeletal , Resistance Training , Humans , Female , Resistance Training/methods , Male , Muscle Fatigue/physiology , Adult , Young Adult , Muscle, Skeletal/physiology , Muscle, Skeletal/blood supply , Regional Blood Flow , Torque , Myalgia/etiology , Myalgia/prevention & control , Perception/physiology , Oxygen Consumption , Blood Flow Restriction Therapy/methods , Electromyography , Knee/physiology
3.
Ann Med ; 56(1): 2355581, 2024 Dec.
Article in English | MEDLINE | ID: mdl-38823421

ABSTRACT

INTRODUCTION: The administration of proton pump inhibitors (PPIs) is anticipated to elevate an individual's susceptibility to enteric infections as a result of altering the gut flora. The influence of PPIs on the clinical manifestation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still uncertain. This study aims to investigate the impact of PPI usage on the clinical manifestation of COVID-19, namely its gastrointestinal symptoms. METHODS: This is a cross-sectional cohort study involving COVID-19 patients. Patients were interviewed using a predesigned questionnaire that asked about their demographics, clinical manifestations of COVID-19 infection, and the extent and type of PPIs in use. PPI usage was confirmed by reviewing patients' electronic medical records. The primary outcome was to establish any association between the use of PPI and the symptoms and clinical presentation of COVID-19. RESULTS: Out of a total of 254 participants, 69 (27.2%) were considered PPI users. Patients who were on PPI medications reported a significantly lower rate of myalgia (27.5% vs 51.9%; p = 0.0006) and heartburn (5.7% vs 15.6%; p = 0.03) but had a significantly higher rate of abdominal pain (27.5% vs 13.5%; p = 0.001) and diarrhoea (28.9% vs 14.5%, p = 0.02) when compared to those who were not using PPIs. Patients on PPIs were also shown to have significantly higher odds of developing diarrhoea (OR 2.0, 95% CI: 1.08 to 3.93, p = 0.02) and abdominal pain (OR 2.0, 95% CI: 1.22 to 3.93, p = 0.03), but a lower risk of developing myalgia (OR 0.5, 95% CI: 0.3 to 0.9, p = 0.02) when compared to non-PPI users. CONCLUSION: This study shows that the use of PPIs could impact COVID-19 clinical presentation toward more gastrointestinal manifestations. Further studies investigating the link between other acid suppression medications and COVID-19 manifestations and severity should be carried out.


Subject(s)
COVID-19 , Gastrointestinal Diseases , Proton Pump Inhibitors , SARS-CoV-2 , Humans , Proton Pump Inhibitors/adverse effects , Proton Pump Inhibitors/therapeutic use , Male , Female , Cross-Sectional Studies , COVID-19/epidemiology , COVID-19/complications , Middle Aged , Adult , Gastrointestinal Diseases/chemically induced , Gastrointestinal Diseases/epidemiology , Aged , Abdominal Pain/chemically induced , Abdominal Pain/etiology , Heartburn/chemically induced , Myalgia/chemically induced , Myalgia/epidemiology , Diarrhea/chemically induced , Diarrhea/epidemiology , Diarrhea/virology
4.
BMJ Case Rep ; 17(6)2024 Jun 05.
Article in English | MEDLINE | ID: mdl-38839420

ABSTRACT

We report a case of a woman in her early 80s with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis presented as myalgia mimicking polymyalgia rheumatica (PMR). She had positive results for the Neer and Hawkins-Kennedy impingement tests, and a normal serum creatine kinase (CK) concentration. At first, we suspected PMR; however, the patient did not strictly meet the classification criteria. Electromyography revealed an abnormal myogenic pattern, and muscle MRI revealed intramuscular and fascial hyperintensity. Moreover, chest CT revealed interstitial lung disease, and test results for ANCAs were positive. We diagnosed the patient with ANCA-associated vasculitis based on the criteria and treated her with corticosteroids and rituximab. Thus, ANCA-associated vasculitis can cause muscle involvement without elevation of the CK concentration and mimic PMR.


Subject(s)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis , Polymyalgia Rheumatica , Humans , Polymyalgia Rheumatica/diagnosis , Polymyalgia Rheumatica/drug therapy , Female , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/diagnosis , Diagnosis, Differential , Aged, 80 and over , Rituximab/therapeutic use , Magnetic Resonance Imaging , Electromyography , Myalgia/etiology
5.
BMC Res Notes ; 17(1): 171, 2024 Jun 20.
Article in English | MEDLINE | ID: mdl-38902784

ABSTRACT

OBJETIVE: this study was to determine the relationship between acute febrile illness and bacterial pathogens with zoonotic potential that cause emerging and re-emerging diseases in a central-eastern region of Peru. RESULTS: Out of the 279 samples analyzed, 23 (8.2%) tested positive for infection by Rickettsia spp., while a total of 15 (5.4%) tested positive for Leptospira spp. Women had a higher frequency of infection by Rickettsia spp., with 13 cases (53.3%), while men had a higher frequency of infection by Leptospira spp., with 10 cases (66.7%). The most frequently reported general symptom was headache, with 100.0% (n = 23) of patients with Rickettsia (+) and 86.7% (n = 13) of patients with Leptospira (+) experiencing it. Arthralgia was the second most frequent symptom, reported by 95.6% (n = 22) and 60% (n = 9) of patients with Rickettsia (+) and Leptospira (+), respectively. Myalgia was reported by 91.3% (n = 21) and 66.7% (n = 10) of patients with Rickettsia (+) and Leptospira (+), respectively. Retroocular pain, low back pain, and skin rash were also present, but less frequently. Among the positives, no manifestation of bleeding was recorded, although only one positive case for Leptospira spp. presented a decrease in the number of platelets.


Subject(s)
Leptospira , Leptospirosis , Rickettsia Infections , Rickettsia , Humans , Peru/epidemiology , Rickettsia/isolation & purification , Female , Male , Leptospira/isolation & purification , Leptospira/pathogenicity , Leptospirosis/epidemiology , Leptospirosis/microbiology , Leptospirosis/complications , Leptospirosis/diagnosis , Rickettsia Infections/epidemiology , Rickettsia Infections/microbiology , Rickettsia Infections/diagnosis , Adult , Animals , Fever/microbiology , Zoonoses/microbiology , Zoonoses/diagnosis , Zoonoses/epidemiology , Myalgia/microbiology , Myalgia/epidemiology , Middle Aged , Young Adult , Adolescent , Headache/microbiology , Headache/etiology , Headache/epidemiology , Arthralgia/microbiology , Arthralgia/etiology
6.
Clin Ter ; 175(3): 154-162, 2024.
Article in English | MEDLINE | ID: mdl-38767072

ABSTRACT

Background: Rising global concerns about COVID-19 recently gained more research attention due to the ease of person-to-person transmission, various symptoms after healing, and the shortage of effective antiviral therapy. The study aims to analyze post-COVID conditions and clinical manifestations of cardiovascular lesions in patients recovering from COVID-19 infection. Methods: A practical examination of post-COVID conditions manifestation was conducted in a prospective cohort study, involving 250 patients diagnosed with COVID-19 between June 1, 2021, and August 31, 2021. The study specifically focused on analyzing the cardiovascular effects of COVID-19, utilizing data from a subgroup of 200 patients previously discharged from the hospital with elevated troponin levels. The cardiovascular variables assessed included tachycardia, ischemia, heart attack, myocarditis, hypertension, blood clots, and heart failure. Results: It has been observed that among surviving patients, the following symptoms persisted: anosmia/ageusia (59%), severe dyspnea (36.7%), palpitations and complaints related to the cardiovascular sys-tem (15.8%), headaches (13.2%), arthralgia (11.7%), myalgia (9.8%), and hair problems (≥5%). By the 60th day, a reduction in symptoms by 5-10% was noted, and by the 90th day, a decrease in activity by 25-35% was observed. Patients aged 40-60 years exhibited the highest percentage of cardiovascular diseases (75%). Conclusions: Consequently, the SARS-CoV-2 virus underscores the critical importance of cardiological attention in patient care. Cardiac screening results in individuals with COVID-19 reveal a significant prevalence of serious heart problems, affecting over half of the patients. This emphasizes the necessity for heightened vigilance and specialized cardiac care when managing patients with COVID-19.


Subject(s)
COVID-19 , Cardiovascular Diseases , Humans , COVID-19/complications , Male , Middle Aged , Female , Prospective Studies , Adult , Cardiovascular Diseases/etiology , Cardiovascular Diseases/epidemiology , Aged , Post-Acute COVID-19 Syndrome , Anosmia/etiology , Myalgia/etiology , Arthralgia/etiology , Headache/etiology , Dyspnea/etiology
7.
Prim Care ; 51(2): 311-326, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38692777

ABSTRACT

Muscle weakness and pain can be seen in orthopedic, rheumatologic, cardiac, and musculoskeletal conditions in addition to neurologic disorders. Myopathy, which describes a heterogenous group of hereditary and acquired disorders that affect muscle channels, structure, and metabolism, is one possible cause. This review focuses on essential information to support primary care providers as they assess patients with muscle weakness and pain for myopathy. As with most neurologic disorders, a thorough clinical history and physical examination are essential first steps. These findings will then guide diagnostic testing and facilitate appropriate management or referral for further neuromuscular care.


Subject(s)
Muscle Weakness , Muscular Diseases , Physical Examination , Humans , Muscle Weakness/diagnosis , Muscular Diseases/diagnosis , Primary Health Care , Myalgia/diagnosis , Diagnosis, Differential , Medical History Taking
8.
Scand J Med Sci Sports ; 34(5): e14643, 2024 May.
Article in English | MEDLINE | ID: mdl-38700004

ABSTRACT

PURPOSE: Delayed structural and functional recovery after a 20 km graded running race was analyzed with respect to the sex effect. METHODS: Thirteen female and 14 male recreational runners completed the race and three test sessions: one before (PRE) and two after, once on Day 1 or 2 (D1-2) and then on Day 3 or 4 (D3-4). Muscle damage was assessed indirectly using ultrasonography to quantify changes in cross-sectional area (CSA) of 10 lower-limb muscles. Delayed onset of muscle soreness (DOMS) was assessed for three muscle groups. Functional recovery was quantified by kinetic analysis of a squat jump (SJ) and a drop jump (DJ) test performed on a sledge ergometer. Linear mixed models were used to assess control group reproducibility and recovery patterns according to sex. RESULTS: Regardless of sex, DOMS peaked at D1-2 for all muscle groups and resolved at D3-4. CSA was increased in each muscle group until D3-4, especially in the semimembranosus muscle. A specific increase was found in the short head of the biceps femoris in women. Regardless of sex, SJ and DJ performances declined up to D3-4. Depending on the muscle, positive and/or negative correlations were found between structural and functional changes. Some of these were sex-specific. CONCLUSION: Structural and functional recovery was incomplete in both sexes up to D3-4, although DOMS had disappeared. More emphasis should be placed on hamstring muscle recovery. Highlighting the intermuscular compensations that can occur during multi-joint testing tasks, the structural-functional relationships were either positive or negative, muscle- and sex-dependent.


Subject(s)
Lower Extremity , Muscle, Skeletal , Myalgia , Ultrasonography , Humans , Female , Myalgia/physiopathology , Male , Adult , Muscle, Skeletal/physiology , Muscle, Skeletal/diagnostic imaging , Lower Extremity/physiology , Lower Extremity/diagnostic imaging , Sex Factors , Running/physiology , Young Adult , Recovery of Function , Athletic Performance/physiology
9.
J Electromyogr Kinesiol ; 76: 102882, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38599050

ABSTRACT

This research aimed to determine whether triceps surae delayed onset muscle soreness (DOMS) affects stability while performing different postural control tasks requiring upright and landing stabilization. Twenty-four participants who self-reported as healthy were recruited. Pre and 48 h after a protocol to induce DOMS in the triceps surae, participants were evaluated for DOMS perception, pressure pain threshold, and postural control (assessed by the center of pressure, CoP) during different standing and landing stabilization tasks. We found higher DOMS perception and lower pressure pain threshold 48 h after the exercise. Mediolateral CoP displacement was more sensitive to DOMS across different postural tasks, but no effects were found for bilateral standing. The landing time to stabilization elicited high individual variability in the presence of DOMS. Effects of DOMS in the performance of less challenging tasks, such as bipedal standing, were not found. We conclude that DOMS in the triceps surae impairs mediolateral postural control during challenging tasks such as unilateral standing and body forward lean. It highlights the need for caution and individualized approaches when incorporating movements requiring frontal plane control in training and rehabilitation sessions under the presence of DOMS.


Subject(s)
Muscle, Skeletal , Myalgia , Postural Balance , Posture , Humans , Male , Myalgia/physiopathology , Myalgia/etiology , Muscle, Skeletal/physiopathology , Muscle, Skeletal/physiology , Postural Balance/physiology , Female , Posture/physiology , Adult , Exercise/physiology , Young Adult , Pain Threshold/physiology
10.
Hum Mov Sci ; 95: 103219, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38636393

ABSTRACT

PURPOSE: Neural and peripheral effects of induced muscle pain on explosive force production were investigated. METHODS: Nine participants performed two maximal, six explosive, and six electrical stimulations induced (twitches and octets) isometric knee extensions before and after (15 min of rest) receiving an intramuscular injection of hypertonic saline (pain inducer) or isotonic (placebo) infusions in two laboratory visits separated by 7 days. RESULTS: It was observed a reduction of peak torque production in maximal voluntary contraction in both conditions (9.3 and 3.3% for pain and placebo, respectively) and in the rate of torque development in placebo (7%). There was an increase in the rate of torque development for twitch and octets (10.5 and 15.8%, respectively) in the pain condition and peak torque for twitch (12%) in both conditions (as did the total rate of torque development for octets). CONCLUSION: Force production decreases and increases during voluntary and involuntary contractions, respectively, suggesting that acute pain impairs force production via central mechanisms.


Subject(s)
Electric Stimulation , Isometric Contraction , Myalgia , Torque , Humans , Male , Isometric Contraction/physiology , Myalgia/physiopathology , Adult , Young Adult , Saline Solution, Hypertonic , Muscle, Skeletal , Female , Electromyography
11.
Rev. esp. anestesiol. reanim ; 71(4): 324-331, abril 2024.
Article in Spanish | IBECS | ID: ibc-232128

ABSTRACT

La succinilcolina es el bloqueador neuromuscular de referencia para la inducción de secuencia rápida. Sin embargo, su uso se asocia a fasciculaciones y mialgias. Se realizó una revisión sistemática y un metaanálisis. Se incluyeron ensayos clínicos controlados aleatorizados comparando gabapentinoides frente a placebo, para la prevención de fasciculaciones y mialgias inducidas por succinilcolina. Se incluyeron seis estudios clínicos aleatorizados. El número total de pacientes fue de 481, de los cuales 241 se incluyeron en el grupo de intervención y 240 en el grupo de placebo. Los gabapentinoides redujeron la incidencia de mialgia inducida por succinilcolina (RR=0,69; IC95%: 0,56-0,84; p<0,001), que siguió siendo estadísticamente significativa para pregabalina (RR=0,71; IC95%: 0,54-0,93; p=0,013) y gabapentina (RR=0,61; IC95%: 0,45-0,82; p=0,001) por separado. No hubo diferencia entre los grupos en cuanto a fasciculaciones (RR=0,92; IC95%: 0,82-1,03; p=0,148). El uso preoperatorio de gabapentinoides se asocia a una menor incidencia de mialgias inducidas por succinilcolina dentro de las primeras 24horas posteriores al procedimiento. (AU)


Succinylcholine is the gold standard neuromuscular blocker for rapid sequence induction, however, its use is associated with fasciculations and myalgias. A systematic review and meta-analysis including randomized controlled clinical trials was performed comparing gabapentinoids versus placebo for the prevention of fasciculations and succinylcholine-induced myalgias. Six randomized clinical studies were included. The total number of patients was 481, of which 241 were in the intervention group and 240 in the placebo group. Gabapentinoids reduced the incidence of succinylcholine-induced myalgia (RR=.69; 95%CI: .56-.84; P<.001), which remained statistically significant for pregabalin (RR=.71; 95%CI: .54-.93; P=.013) and gabapentin (RR=.61; 95%CI: .45-.82; P=.001) separately. There was no difference between the groups in fasciculations (RR=.92; 95%CI: .82-1.03; P=.148). Preoperative use of gabapentinoids is associated with lower incidence of succinylcholine-induced myalgias within the first 24hours after the procedure. (AU)


Subject(s)
Humans , Fasciculation , Myalgia , Pregabalin , Gabapentin , Succinylcholine
12.
Scand J Pain ; 24(1)2024 Jan 01.
Article in English | MEDLINE | ID: mdl-38625666

ABSTRACT

OBJECTIVES: The etiology of fibromyalgia (FM) is disputed, and there is no established cure. Quantitative data on how this may affect patients' healthcare experiences are scarce. The present study aims to investigate FM patients' pain-related healthcare experiences and explore factors associated with high satisfaction and pain relief. METHODS: An anonymous, online, and patient-administered survey was developed and distributed to members of the Norwegian Fibromyalgia Association. It addressed their pain-related healthcare experiences from both primary and specialist care. Odds ratios for healthcare satisfaction and pain relief were estimated by binary logistic regression. Directed acyclic graphs guided the multivariable analyses. RESULTS: The patients (n = 1,626, mean age: 51 years) were primarily women (95%) with a 21.8-year mean pain duration and 12.7 years in pain before diagnosis. One-third did not understand why they had pain, and 56.6% did not know how to get better. More than half had not received satisfactory information on their pain cause from a physician, and guidance on how to improve was reported below medium. Patients regretted a lack of medical specialized competence on muscle pain and reported many unmet needs, including regular follow-up and pain assessment. Physician-mediated pain relief was low, and guideline adherence was deficient. Only 14.8% were satisfied with non-physician health providers evaluating and treating their pain, and 21.5% were satisfied (46.9% dissatisfied) with their global pain-related healthcare. Patients' knowledge of their condition, physicians' pain competence and provision of information and guidance, agreement in explanations and advice, and the absence of unmet needs significantly increased the odds of both healthcare satisfaction and pain relief. CONCLUSIONS: Our survey describes deficiencies in FM patients' pain-related healthcare and suggests areas for improvement to increase healthcare satisfaction and pain relief. (REC# 2019/845, 09.05.19).


Subject(s)
Fibromyalgia , Patient Satisfaction , Humans , Female , Middle Aged , Fibromyalgia/therapy , Pain Management , Myalgia , Emotions
13.
JAMA Netw Open ; 7(4): e244386, 2024 Apr 01.
Article in English | MEDLINE | ID: mdl-38573638

ABSTRACT

Importance: Many patients with post-COVID condition (PCC) experience persistent fatigue, muscle pain, and cognitive problems that worsen after exertion (referred to as postexertional malaise). Recommendations currently advise against exercise in this population to prevent symptom worsening; however, prolonged inactivity is associated with risk of long-term health deterioration. Objective: To assess postexertional symptoms in patients with PCC after exercise compared with control participants and to comprehensively investigate the physiologic mechanisms underlying PCC. Design, Setting, and Participants: In this randomized crossover clinical trial, nonhospitalized patients without concomitant diseases and with persistent (≥3 months) symptoms, including postexertional malaise, after SARS-CoV-2 infection were recruited in Sweden from September 2022 to July 2023. Age- and sex-matched control participants were also recruited. Interventions: After comprehensive physiologic characterization, participants completed 3 exercise trials (high-intensity interval training [HIIT], moderate-intensity continuous training [MICT], and strength training [ST]) in a randomized order. Symptoms were reported at baseline, immediately after exercise, and 48 hours after exercise. Main Outcomes and Measures: The primary outcome was between-group differences in changes in fatigue symptoms from baseline to 48 hours after exercise, assessed via the visual analog scale (VAS). Questionnaires, cardiopulmonary exercise testing, inflammatory markers, and physiologic characterization provided information on the physiologic function of patients with PCC. Results: Thirty-one patients with PCC (mean [SD] age, 46.6 [10.0] years; 24 [77%] women) and 31 healthy control participants (mean [SD] age, 47.3 [8.9] years; 23 [74%] women) were included. Patients with PCC reported more symptoms than controls at all time points. However, there was no difference between the groups in the worsening of fatigue in response to the different exercises (mean [SD] VAS ranks for HIIT: PCC, 29.3 [19.5]; controls, 28.7 [11.4]; P = .08; MICT: PCC, 31.2 [17.0]; controls, 24.6 [11.7]; P = .09; ST: PCC, 31.0 [19.7]; controls, 28.1 [12.2]; P = .49). Patients with PCC had greater exacerbation of muscle pain after HIIT (mean [SD] VAS ranks, 33.4 [17.7] vs 25.0 [11.3]; P = .04) and reported more concentration difficulties after MICT (mean [SD] VAS ranks, 33.0 [17.1] vs 23.3 [10.6]; P = .03) compared with controls. At baseline, patients with PCC showed preserved lung and heart function but had a 21% lower peak volume of oxygen consumption (mean difference: -6.8 mL/kg/min; 95% CI, -10.7 to -2.9 mL/kg/min; P < .001) and less isometric knee extension muscle strength (mean difference: -37 Nm; 95% CI, -67 to -7 Nm; P = .02) compared with controls. Patients with PCC spent 43% less time on moderate to vigorous physical activity (mean difference, -26.5 minutes/d; 95% CI, -42.0 to -11.1 minutes/d; P = .001). Of note, 4 patients with PCC (13%) had postural orthostatic tachycardia, and 18 of 29 (62%) showed signs of myopathy as determined by neurophysiologic testing. Conclusions and Relevance: In this study, nonhospitalized patients with PCC generally tolerated exercise with preserved cardiovascular function but showed lower aerobic capacity and less muscle strength than the control group. They also showed signs of postural orthostatic tachycardia and myopathy. The findings suggest cautious exercise adoption could be recommended to prevent further skeletal muscle deconditioning and health impairment in patients with PCC. Trial Registration: ClinicalTrials.gov Identifier: NCT05445830.


Subject(s)
COVID-19 , Female , Humans , Male , Middle Aged , Fatigue/etiology , Myalgia/etiology , SARS-CoV-2 , Tachycardia , Adult , Cross-Over Studies
14.
Sheng Li Xue Bao ; 76(2): 301-308, 2024 Apr 25.
Article in Chinese | MEDLINE | ID: mdl-38658378

ABSTRACT

Delayed-onset muscle soreness (DOMS) is a common phenomenon that occurs following a sudden increase in exercise intensity or unfamiliar exercise, significantly affecting athletic performance and efficacy in athletes and fitness individuals. DOMS is characterized by allodynia and hyperalgesia, and their mechanisms remain unclear. Recent studies have reported that neurotrophic factors, such as nerve growth factor (NGF) and glial cell derived neurotrophic factor (GDNF), are involved in the development and maintenance of DOMS. This article provides a review of the research progress on the signaling pathways related to the involvement of NGF and GDNF in DOMS, hoping to provide novel insights into the mechanisms underlying allodynia and hyperalgesia in DOMS, as well as potential targeted treatment.


Subject(s)
Glial Cell Line-Derived Neurotrophic Factor , Myalgia , Nerve Growth Factor , Humans , Myalgia/physiopathology , Nerve Growth Factor/metabolism , Nerve Growth Factor/physiology , Glial Cell Line-Derived Neurotrophic Factor/metabolism , Glial Cell Line-Derived Neurotrophic Factor/physiology , Signal Transduction , Animals , Hyperalgesia/physiopathology , Muscle, Skeletal/physiopathology , Muscle, Skeletal/physiology , Exercise/physiology
15.
Scand J Med Sci Sports ; 34(4): e14615, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38556845

ABSTRACT

We investigated the effects of far-infrared radiation (FIR) lamp therapy on changes in muscle damage and performance parameters following six sets of 15-min Loughborough intermittent shuttle test (LIST), a simulated soccer match. Twenty-four elite female soccer players (20-24 y) were assigned into FIR or sham treatment group (n = 12/group). The participants received a 60-min FIR or sham treatment (30 min per muscle) over knee extensors (KE) and flexors (KF) at 2, 25, 49, 73, and 97 h post-LIST. Maximal voluntary isometric contraction (MVC) torque and muscle soreness of the KE and KF, plasma creatine kinase (CK) activity as muscle damage markers, and several performance parameters including countermovement jump (CMJ) and Yo-Yo intermittent recovery test level 1 (YYIR1) were measured before and 1, 24, 48, 72, 96, and 120 h post-LIST. Changes in the measures were compared between groups by a mixed-design two-way ANOVA. The running distance covered during LIST and changes in the measures at 1-h post-LIST (before the treatment) were similar (p = 0.118-0.371) between groups. Changes in muscle damage markers at 24-120 h post-LIST were smaller (p < 0.05, η2 = 0.208-0.467) for the FIR (e.g., MVC-KE torque decrease at 48-h post-LIST: -1 ± 2%, peak KE soreness: 16 ± 10 mm, peak CK: 172 ± 42 IU/L) than sham group (-11 ± 9%, 33 ± 7 mm, 466 ± 220 IU/L, respectively). Performance parameters recovered faster (p < 0.05, η2 = 0.142-0.308) to baseline for the FIR (e.g., decreases at 48-h post-LIST; CMJ: 0 ± 1%, YYIR1: 0 ± 1%) than sham group (-6 ± 2%, -9 ± 6%, respectively). These results suggest that the FIR lamp therapy was effective for enhancing recovery from a soccer match.


Subject(s)
Athletic Performance , Soccer , Humans , Female , Soccer/physiology , Myalgia/radiotherapy , Knee/physiology , Knee Joint , Athletic Performance/physiology
16.
Vaccine ; 42(12): 3009-3017, 2024 Apr 30.
Article in English | MEDLINE | ID: mdl-38575433

ABSTRACT

BACKGROUND: Bio Farma has developed a recombinant protein subunit vaccine (IndoVac) that is indicated for active immunization in population of all ages. This article reported the results of the phase 3 immunogenicity and safety study in Indonesian adults aged 18 years and above. METHODS: We conducted a randomized, active-controlled, multicenter, prospective intervention study to evaluate the immunogenicity and safety of IndoVac in adults aged 18 years and above. Participants who were SARS-CoV-2 vaccine-naïve received two doses of either IndoVac or control (Covovax) with 28 days interval between doses and were followed up until 12 months after complete vaccination. RESULTS: A total of 4050 participants were enrolled from June to August 2022 and received at least one dose of vaccine. The geometric mean ratio (GMR) of neutralizing antibody at 14 days after the second dose was 1.01 (95 % confidence interval (CI) 0.89-1.16), which met the WHO non-inferiority criteria for immunobridging (95 % CI lower bound > 0.67). The antibody levels were maintained through 12 months after the second dose. The incidence rate of adverse events (AEs) were 27.95 % in IndoVac group and 32.15 % in Covovax group with mostly mild intensity (27.70 %). The most reported solicited AEs were pain (14.69 %) followed by myalgia (7.48 %) and fatigue (6.77 %). Unsolicited AEs varied, with each of the incidence rate under 5 %. There were no serious AEs assessed as possibly, probably, or likely related to vaccine. CONCLUSIONS: IndoVac in adults showed favourable safety profile and elicited non-inferior immune response to Covovax. (ClinicalTrials.gov: NCT05433285, Indonesian Clinical Research Registry: INA-R5752S9).


Subject(s)
Alum Compounds , COVID-19 , Protein Subunit Vaccines , Adult , Humans , SARS-CoV-2 , COVID-19 Vaccines/adverse effects , Indonesia , Prospective Studies , COVID-19/prevention & control , Adjuvants, Immunologic , Antibodies, Neutralizing , Myalgia , Immunogenicity, Vaccine , Antibodies, Viral , Double-Blind Method
18.
J Nutr Health Aging ; 28(5): 100204, 2024 May.
Article in English | MEDLINE | ID: mdl-38460318

ABSTRACT

OBJECTIVES: We compared the effect of 12 weeks lesser mealworm-based (Alphitobius diaperinus) protein supplementation to whey protein and placebo supplementation on Exercise-Induced Muscle Damage (EIMD) after long-distance walking in older adults. METHODS: in this randomized controlled trial, 70 physically active older adults (>60 years) were randomly allocated to the following groups: I) lesser mealworm protein, II) whey protein or III) iso-caloric placebo. Participants received supplements 11 weeks before and 1 week during a 3-day long-distance walking challenge (30-50 km per day). Blood concentrations of creatinine kinase (CK) and lactate dehydrogenase (LDH), handgrip strength and muscle soreness were measured pre-exercise and directly after each walking bout. RESULTS: Significant elevations of CK concentrations (103 [76-161] U/l to 758 [342-1104] U/l, p < 0.001) and LDH concentrations (202 [175-220] to 283 [252-339] U/l, p < 0.001) were observed following 7h45 min ± 11 min of walking exercise per day, but the magnitude of this effect did not differ among suppletion groups. Hand grip strength decreased significantly (p < 0.001) while muscle soreness increased (p = 0.002) after the first walking day compared to pre-exercise, with no group differences. CONCLUSION: 12-weeks of lesser mealworm-based protein supplementation (30 g/day) does not attenuate exercise induced muscle damage in older adults following three days of prolonged walking exercise in comparison to placebo or whey protein.


Subject(s)
Creatine Kinase , Dietary Supplements , Hand Strength , L-Lactate Dehydrogenase , Muscle, Skeletal , Myalgia , Walking , Whey Proteins , Humans , Aged , Male , Female , Muscle, Skeletal/drug effects , Whey Proteins/administration & dosage , L-Lactate Dehydrogenase/blood , Creatine Kinase/blood , Middle Aged , Animals , Exercise/physiology , Helminth Proteins , Dietary Proteins/administration & dosage
19.
J Appl Physiol (1985) ; 136(4): 889-900, 2024 Apr 01.
Article in English | MEDLINE | ID: mdl-38450425

ABSTRACT

Resistance training at longer muscle lengths induces greater muscle hypertrophy and different neuromuscular functional adaptations than training at shorter muscle lengths. However, the acute time course of recovery of neuromuscular characteristics after resistance exercise at shorter and longer muscle lengths in the quadriceps has never been described. Eight healthy young participants (4 M, 4 F) were randomly assigned to perform four sets of eight maximal isometric contractions at shorter (SL; 50° knee flexion) or longer (LL; 90° knee flexion) muscle lengths in a crossover fashion. During exercise, peak torque (PT), muscle activity [electromyogram (EMG)], and internal muscle forces were assessed. PT and EMG at shorter (PT50, EMG50) and longer (PT90, EMG90) muscle lengths, creatine kinase (CK), and muscle soreness were measured at baseline, immediately after exercise (Post), after 24 h (24 h), and after 48 h (48 h). During exercise, EMG (P = 0.002) and internal muscle forces (P = 0.017) were greater in LL than in SL. During recovery, there was a main effect of exercise angle, with PT50 (P = 0.002), PT90 (P = 0.016), and EMG50 (P = 0.002) all significantly reduced to a greater degree in LL compared with SL. CK and muscle soreness increased after resistance exercise, but there were no differences between SL and LL. The present results suggest that if the preceding isometric resistance exercise is performed at longer muscle lengths, function and muscle activity at shorter and longer muscle lengths are inhibited to a larger degree in the subsequent recovery period. This information can be used by practitioners to manipulate exercise prescription.NEW & NOTEWORTHY Despite the established long-term benefits of training at longer muscle lengths for muscle size and strength, acutely performing resistance exercise at longer muscle lengths may require a longer time course of neuromuscular recovery compared with performing resistance exercises at shorter muscle lengths. Furthermore, there appear to be different joint angle-specific recovery profiles, depending on the muscle length of the preceding exercise.


Subject(s)
Muscle, Skeletal , Resistance Training , Humans , Creatine Kinase , Electromyography , Isometric Contraction/physiology , Muscle, Skeletal/physiology , Myalgia , Quadriceps Muscle , Resistance Training/methods , Torque , Male , Female
20.
J Clin Psychopharmacol ; 44(3): 297-301, 2024.
Article in English | MEDLINE | ID: mdl-38506608

ABSTRACT

PURPOSE: This systematic review aimed to investigate the clinical manifestations and characteristics of venlafaxine-associated rhabdomyolysis. METHODS: A systematic search was conducted in PubMed, Elsevier, Science Direct, Embase, Springer Link, Wiley Online Library, CNKI, and Wanfang databases from the date of database inception to January 2023. Previously reported cases of venlafaxine-associated rhabdomyolysis were identified, and relevant data from these cases were collected for descriptive statistical analysis. Cases that met the inclusion criteria were evaluated to determine the correlation between adverse reactions and venlafaxine. RESULTS: A total of 12 patients with venlafaxine-associated rhabdomyolysis were included. None of these patients had a history of muscle pain or discomfort. Of the 12 patients, 5 patients received venlafaxine at doses of ≤225 mg/d, whereas the remaining 7 patients received doses exceeding 225 mg/d. The main clinical symptoms included myalgia, muscle weakness, and renal injury. All 12 patients discontinued venlafaxine and received symptomatic care. CONCLUSIONS: Venlafaxine, used either as a monotherapy or in combination with other drugs, may be associated with rhabdomyolysis. Creatine kinase levels may normalize or significantly decrease after discontinuation of venlafaxine and symptomatic treatment.


Subject(s)
Rhabdomyolysis , Venlafaxine Hydrochloride , Rhabdomyolysis/chemically induced , Venlafaxine Hydrochloride/adverse effects , Venlafaxine Hydrochloride/administration & dosage , Humans , Male , Adult , Female , Middle Aged , Creatine Kinase/blood , Myalgia/chemically induced
SELECTION OF CITATIONS
SEARCH DETAIL
...